We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks.
On December 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from 7 to 2 while maintaining an Overweight rating, reflecting confidence in the company’s positioning in life sciences tools and expectations of stabilizing end‑market demand. Barclays cited improving conditions for research funding and the tools sector as part of its positive outlook.
In contrast, on December 11, 2025, Citigroup downgraded 10x Genomics, Inc. (NASDAQ:TXG) from Buy to Neutral with an 8 price target, highlighting uncertainty about capital expenditures in academic and biopharma research that could weigh on instrument sales recovery.
These differing assessments are grounded in the recent operational context. For the full‑year 2024, 10x Genomics, Inc. (NASDAQ:TXG) reported revenue of approximately 10.8 million, a slight year‑over‑year decline, reflecting soft demand in some core research segments. Analyst caution also stems from guidance for 2025 that implies modest growth, with revenue expected to be roughly flat given continued funding uncertainty in key markets.
10x Genomics, Inc. (NASDAQ:TXG) is a biotechnology company that develops advanced tools for high‑resolution genomic analysis, especially single‑cell and spatial biology technologies. It is not a traditional gene‑editing therapeutic developer (e.g., it does not create CRISPR‑based drugs), but its platforms are widely used to analyze the effects of gene editing in cells and tissues.
While we acknowledge the risk and potential of TXG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TXG and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
NASDAQ:TXGYahoo Finance10x Genomics Inc. (NASDAQ:TXG)
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript
10x Genomics Settles Patent Dispute With Bruker
10x Genomics, Inc. (NASDAQ:TXG) Q2 2025 Earnings Call Transcript
10 Best Digital Health Stocks to Buy Now
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch...
50% S&P 500 ETF and 50% Russell 2000 ETF
Returns since its inception in May 2014 (through August 15th, 2025)
30 day money back guarantee. Cancel anytime.
How to Best Use Insider Monkey to Increase Your Returns
Why You Should DUMP Your Hedge Funds
6 Things You Didn't Know About Hedge Funds
11 Best Cancer Stocks to Buy Right Now
40 Most Unfriendly Countries in the World
30 Unhappiest Countries in the World in 2025
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
5 Countries with the Most Beautiful Women in the World
20 Countries with the Most Beautiful Women in the World
20 US Cities with the Highest Homeless Population Per Capita
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World